<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02496312</url>
  </required_header>
  <id_info>
    <org_study_id>C15-14</org_study_id>
    <secondary_id>2015-A0087-42</secondary_id>
    <nct_id>NCT02496312</nct_id>
  </id_info>
  <brief_title>Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.</brief_title>
  <acronym>ECOCAPTURE</acronym>
  <official_title>Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated in Healthy Subjects and Patients With Frontotemporal Dementia. Pilot Phase.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to provide relevant quantitative evaluation of apathy close to
      real life situation by means of a multimodal sensor system integrated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators try to measure the amount of goal-directed behaviour and to detect the
      pattern of apathy. The main objective of this pilot phase is to select the variables of
      goal-directed behaviour from the list of metrics providing by the multimodal acquisition
      system in healthy subjects and patients with frontotemporal dementia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 10, 2015</start_date>
  <completion_date type="Actual">October 2, 2015</completion_date>
  <primary_completion_date type="Actual">October 2, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of each behavior from the ethogram</measure>
    <time_frame>45 min</time_frame>
    <description>[Provided by the video recording and The Observer NOLDUS software]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of each behavior from the ethogram</measure>
    <time_frame>45 min</time_frame>
    <description>[Provided by the video recording and The Observer NOLDUS software]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of each behavior from the ethogram</measure>
    <time_frame>45 mn</time_frame>
    <description>[Provided by the video recording and The Observer NOLDUS software]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of different behaviors</measure>
    <time_frame>45 mn</time_frame>
    <description>[Provided by the video recording and The Observer NOLDUS software]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Activity classes</measure>
    <time_frame>45 mn</time_frame>
    <description>[Provided by the MOVE MOVISENS sensor] lying, sitting, ...</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body positions</measure>
    <time_frame>45 mn</time_frame>
    <description>[Provided by the MOVE MOVISENS sensor] lying left, ...</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Energy expenditure</measure>
    <time_frame>45 mn</time_frame>
    <description>[Provided by the MOVE MOVISENS sensor] kcal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MET</measure>
    <time_frame>45 mn</time_frame>
    <description>[Provided by the MOVE MOVISENS sensor] The Metabolic Equivalent of Task. MET level.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Steps</measure>
    <time_frame>45 mn</time_frame>
    <description>[Provided by the MOVE MOVISENS sensor] Counting steps.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Activity intensity</measure>
    <time_frame>45 mn</time_frame>
    <description>[Provided by the MOVE MOVISENS sensor] g.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Apathy</condition>
  <condition>Behavior</condition>
  <condition>Frontotemporal Dementia</condition>
  <arm_group>
    <arm_group_label>ECOCAPTURE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Evaluation of Apathy Close to Real Life Situation</intervention_name>
    <description>Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.</description>
    <arm_group_label>ECOCAPTURE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Frontotemporal Dementia (FTD) according to diagnostic criteria reported
             by Rascovsky et al. (2011).

          -  Understanding of the instructions and capacity to realize the cognitive tasks.

          -  Capacity to read, to understand and to sign legal document of information

          -  Capacity for informed consent for research, capacity to sign consent

          -  MMSE score &gt; 20

          -  Absence of other cerebral pathology.

          -  Absence of psychiatric disease interfering with the assessment of the tests

          -  Absence of excessive psychotropic use

          -  Access to National Healthcare Insurance

          -  Accompanied with a caregiver

        Exclusion Criteria:

          -  Excessive psychotropic use

          -  Incapacity or refusal to realize the experimental tasks

          -  Subject deprived of freedom by an administrative or court order

          -  Subject under legal protective measure.

          -  Incapacity for informed consent for research

          -  Participation in another biomedical research

          -  Airway obstruction risk

          -  Reduction of activity not attributable to another chronic pathological condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard LEVY, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>INSERM UMR_S 1127, ICM</affiliation>
  </overall_official>
  <reference>
    <citation>Robert PH, Clairet S, Benoit M, Koutaich J, Bertogliati C, Tible O, Caci H, Borg M, Brocker P, Bedoucha P. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry. 2002 Dec;17(12):1099-105.</citation>
    <PMID>12461757</PMID>
  </reference>
  <reference>
    <citation>Pasquier F, Lebert F, Lavenu I, Guillaume B. The clinical picture of frontotemporal dementia: diagnosis and follow-up. Dement Geriatr Cogn Disord. 1999;10 Suppl 1:10-4.</citation>
    <PMID>10436334</PMID>
  </reference>
  <reference>
    <citation>Mayo NE, Fellows LK, Scott SC, Cameron J, Wood-Dauphinee S. A longitudinal view of apathy and its impact after stroke. Stroke. 2009 Oct;40(10):3299-307. doi: 10.1161/STROKEAHA.109.554410. Epub 2009 Aug 27.</citation>
    <PMID>19713543</PMID>
  </reference>
  <reference>
    <citation>Winograd-Gurvich C, Fitzgerald PB, Georgiou-Karistianis N, Bradshaw JL, White OB. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease. Brain Res Bull. 2006 Oct 16;70(4-6):312-21. Epub 2006 Jul 5. Review.</citation>
    <PMID>17027767</PMID>
  </reference>
  <reference>
    <citation>Marin RS, Firinciogullari S, Biedrzycki RC. Group differences in the relationship between apathy and depression. J Nerv Ment Dis. 1994 Apr;182(4):235-9.</citation>
    <PMID>10678322</PMID>
  </reference>
  <reference>
    <citation>Dujardin K, Sockeel P, Delliaux M, Destée A, Defebvre L. The Lille Apathy Rating Scale: validation of a caregiver-based version. Mov Disord. 2008 Apr 30;23(6):845-9. doi: 10.1002/mds.21968.</citation>
    <PMID>18307266</PMID>
  </reference>
  <reference>
    <citation>Lane-Brown AT, Tate RL. Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. Neuropsychol Rehabil. 2009 Aug;19(4):481-516. doi: 10.1080/09602010902949207. Review.</citation>
    <PMID>19533496</PMID>
  </reference>
  <reference>
    <citation>Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y, Dubois B. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):775-9.</citation>
    <PMID>15897497</PMID>
  </reference>
  <reference>
    <citation>Le Jeune F, Drapier D, Bourguignon A, Péron J, Mesbah H, Drapier S, Sauleau P, Haegelen C, Travers D, Garin E, Malbert CH, Millet B, Vérin M. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology. 2009 Nov 24;73(21):1746-51. doi: 10.1212/WNL.0b013e3181c34b34.</citation>
    <PMID>19933975</PMID>
  </reference>
  <reference>
    <citation>Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 1991 Summer;3(3):243-54. Review.</citation>
    <PMID>1821241</PMID>
  </reference>
  <reference>
    <citation>Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex. 2006 Jul;16(7):916-28. Epub 2005 Oct 5. Review.</citation>
    <PMID>16207933</PMID>
  </reference>
  <reference>
    <citation>Levy R, Czernecki V. Apathy and the basal ganglia. J Neurol. 2006 Dec;253 Suppl 7:VII54-61. Review.</citation>
    <PMID>17131230</PMID>
  </reference>
  <reference>
    <citation>Brown RG, Pluck G. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. Trends Neurosci. 2000 Sep;23(9):412-7. Review.</citation>
    <PMID>10941190</PMID>
  </reference>
  <reference>
    <citation>Müller U, Czymmek J, Thöne-Otto A, Von Cramon DY. Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy. Brain Inj. 2006 Feb;20(2):157-60.</citation>
    <PMID>16421064</PMID>
  </reference>
  <reference>
    <citation>Funkiewiez A, Bertoux M, de Souza LC, Lévy R, Dubois B. The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. Neuropsychology. 2012 Jan;26(1):81-90. doi: 10.1037/a0025318. Epub 2011 Sep 5.</citation>
    <PMID>21895376</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2015</study_first_submitted>
  <study_first_submitted_qc>July 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2015</study_first_posted>
  <last_update_submitted>October 31, 2017</last_update_submitted>
  <last_update_submitted_qc>October 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Apathy</keyword>
  <keyword>Goal-directed behavior</keyword>
  <keyword>Quantitative evaluation</keyword>
  <keyword>Sensor</keyword>
  <keyword>Ethogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Frontotemporal Dementia</mesh_term>
    <mesh_term>Aphasia, Primary Progressive</mesh_term>
    <mesh_term>Pick Disease of the Brain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

